FBR

Company Profile

Portfolio

Presentation

Get Expert Advice

Order

Consult With Us
pharma logo
  • Home
  • Remedies
  • Medical Devices
  • Regulatory Strategy Consultation for SaMD

Regulatory Strategy Consultation for SaMD

For SaMD innovators aiming for swift and compliant market entry, a region-specific regulatory strategy isn’t just necessary—it’s a strategic edge. With the growing adoption of AI diagnostics, real-time monitoring, and mobile health apps, navigating global regulatory frameworks can be complex. Pharma Wizard streamlines this process, guiding you through each step with clarity and confidence.

110+

Global SaMD Regulatory Strategies Delivered

54+

Regulatory Markets Covered

39+

Clients Supported in Initial Classification (novel devices)

1300+

Regulatory Projects Executed Across Lifecycle

Overview

At Pharma Wizard, we specialize in navigating the complex landscape of Software as a Medical Device (SaMD) regulations to accelerate your path to global market access. Our team delivers end-to-end compliance solutions for innovative medical software, ensuring alignment with key standards such as IEC 62304, ISO 13485, and EU MDR/IVDR requirements.

We support seamless regulatory approvals across major markets, including the United States and the European Union. Our experts manage FDA 510(k) submissions to ensure your SaMD complies with all safety, performance, and efficacy requirements. In the EU, we guide you through CE marking under MDR and IVDR, enabling timely and compliant market entry.

With extensive experience in regulatory strategy, technical documentation, gap analysis, and risk management, Pharma Wizard is your trusted partner for fast, compliant, and successful SaMD product launches. Whether you’re targeting FDA clearance, CE marking, or global regulatory harmonization, we offer tailored solutions to help bring your medical software to patients worldwide.

Regulatory Strategy Consultation Services

Our end-to-end regulatory consultation services are tailored to regional requirements and your SaMD’s risk profile. Offerings include:
  • Initial assessment of your SaMD, its functionality, intended use, and market objectives
  • Technical documentation review and compliance gap identification
  • Risk classification based on country-specific regulatory frameworks
  • Mapping of applicable standards (e.g., ISO 13485, IEC 62304, IEC 82304-1)
  • Identification of relevant regulatory pathways such as 510(k), CE, MDL, and others
Each solution is customized based on your product type, target geography, and commercialization timeline.

Regulatory Pathways and In-country Representation

Pharma Wizard’s regulatory experts are well-equipped to guide you through region-specific market access pathways:
  • U.S. FDA: SaMD classification, 510(k), and PMA pathways
  • Europe (EU MDR): Qualification as MDSW and CE conformity via Class I–III routes
  • Japan: PMDA compliance for Class II/III software
Where applicable, we also act as your in-country regulatory representative, providing a local presence and ensuring smooth communication with health authorities for timely approvals.
Regulatory Pathways and In-count

Regulatory Intelligence & Roadmap Development

We provide real-time insights and predictive Regulatory intelligence for your SaMD’s target markets.

Periodic updates on evolving regional requirements (FDA guidance, MDCG notes, PMDA revisions, etc.)

Horizon scanning for Regulatory trends affecting AI/ML-based SaMDs

Competitor pathway mapping and benchmarking

Detailed Regulatory roadmap aligned with your launch plan

Pharma Wizard Regulatory roadmap outlines step-by-step actions across pre-submission, documentation, submission, and post-approval stages-enabling faster decision-making and budget forecasting.
Explore Our SaMD Consulting Capabilities

Global Strategy and Market Expansion

Beyond country-specific compliance, our strategic consultation services support cross-market SaMD expansion.
  • Comparative Regulatory mapping across 20+ regions
  • Product adaptability and submission reuse strategy
  • Cross-functional input from clinical, cybersecurity, and QMS experts
  • Tailored approaches for simultaneous multi-market submissions
As digital health goes global, Regulatory scalability becomes a growth driver.
Explore Global Expansion Strategy
Global-Strategy-and-Market

Challenges vs. Your Benefits with Pharma SaMD Solutions

Key Challenges Your Benefits
1. Complex & Evolving Regulations
Navigating US FDA 21 CFR Part 820, EU MDR, ISO 13485, ISO 14971, IEC 62304, GDPR, and more can delay development without a certified QMS. 		✅ Quick, audit-ready compliance—even when regulations evolve
✅ Pre-built, ISO 13485-compliant QMS available immediately
2. High Costs & Fragmented Efforts
Hiring experts and coordinating with multiple stakeholders (Notified Bodies, Authorities, Consultants) is costly and inefficient. 		✅ Full QARA team for a flat monthly rate
✅ Over 50% cost savings compared to hiring in-house
✅ Less than 1 FTE cost for complete coverage
3. Long & Risk-Prone Timelines
QMS setup (12 months), CE marking (up to 24 months), FDA registration (3–24 months) prolong go-to-market and invite costly errors. 		✅ Save up to 6 months on QMS & ISO certification
✅ Avoid costly rework with expert-led documentation
✅ Save at least €50K on ISO and eQMS costs
✅ 100% success rate in global registrations